| | FEBRUARY 20264 Editorial Vol 4 · Issue 06 - 02 · FEBRUARY, 2026Publisher Alok ChaturvediManaging Editor Rachita Sharma GM - Media & Graphic Designing VisualizerPrabhu Dutta A.R.N RayNoidaRohit Raghubanshi Akshay Shettyadvertise@ceoinsightsasia.comEditorial queries editor@ceoinsightsasia.comTo subscribeVisit www.ceoinsightsasia.com/subscribe/ or send emailto subscription@ceoinsightsasia.comMagazine Price is $50 per issuePublisher Alok ChaturvediPrinted and Published By Alok Chaturvedi on behalf of InfoConnect Web Technologies India Pvt. Ltd., and Printed at Executive Prints - 113/7, Ground floor, Old madras road, Halasuru, Bangalore - 560008 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Copyright © 2026 InfoConnect Web Technologies India Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.Designer Monalisha MalikRugeswaran CVP - Sales & Marketing Amrit Kumar Singh Circulation Manager Magendran PerumalEditorialKeerthana Kantharaj Lakshmi Prabha SViswanathan A Roopalatha H. Meriya Sabu The Iraqi pharmaceutical industry, valued at over $3 billion in 2024, is rapidly growing but remains heavily dependent on imports for over 90% of its medicine needs. While state-owned firms like Samara Drugs Industry (SDI) and private players such as Pioneer Pharma exist, the market is shifting toward localized production and investment. There is a strong, untapped market for investment due to low domestic production capacity. However, challenges include the need for modernization, navigating complex regulations, and competition from imported brands.Navigating the Iraqi pharma sector requires industry expertise and the conviction to build something impactful. The current edition of CEOInsights Asia highlights few pharma leaders from Iraq who are redefining the industry's growth. One of the featured leaders is Fatima Shubber, Managing Director of Shubber Scientific Bureau, is a pharmacist and industry leader who has transformed the company into a trusted representative for global pharmaceutical brands. Since 2010, she has driven partnerships, innovation, and patient-centered initiatives, shaping Iraq's healthcare landscape while promoting quality, access, and ethical leadership.Talking about Iraq's pharma industry, Fatima says, "The pharmaceutical sector in Iraq is evolving rapidly, and challenges will always exist. Approach them with determination and a growth mindset. When you do, every obstacle becomes an opportunity to innovate, grow, and elevate the level of service you provide to your community."To read more such insights and advice, read the current edition of CEOInsights Asia magazine.Let us know your thoughts. Iraq's Pharmaceutical Industry: Challenges & OpportunitiesRachita SharmaManaging Editor editor@ceoinsightsasia.com
< Page 3 | Page 5 >